Kiromic BioPharma Inc. (KRBP)
OTC: KRBP
· Real-Time Price · USD
0.20
0.00 (0.05%)
At close: Mar 24, 2025, 3:59 PM
Kiromic BioPharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.99 | -1.46 | -3.27 | -4.77 | -1.53 | -0.62 | -3.18 | -0.16 | -3.5 | -2.88 | -5.94 | -13.51 | -16.75 | -57.77 | -53.27 | -134.27 |
PEG Ratio | n/a | 0.02 | 1.28 | -0.46 | -0.07 | 0.01 | -0.78 | 0.00 | 0.07 | -0.07 | -0.45 | 0.44 | -0.23 | 1.40 | -1.85 | -16.45 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -2.04 | -4.67 | -17.48 | -16.28 | -3.14 | -2.31 | -13.67 | -0.41 | -17.11 | 485.08 | 17.03 | 19.88 | 26.09 | 37.73 | 217.53 | 244.90 |
P/FCF Ratio | -6.98 | -20.17 | -10.92 | -20.53 | -5.19 | -1.94 | -13.32 | -0.82 | -23.75 | -23.11 | -23.77 | -39.57 | -69.45 | -281.97 | -249.15 | -772.25 |
P/OCF Ratio | -7.04 | -22.45 | -11.05 | -20.6 | -5.3 | -1.98 | -13.32 | -0.82 | -24.08 | -22.61 | -33.61 | -52.54 | -77.77 | -294.09 | -285.83 | -785.35 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.16 | -1.58 | -2.59 | -1.88 | -1.7 | -2.53 | -1.61 | -1.47 | -1.63 | 7.65 | 0.21 | 0.13 | 0.02 | n/a | 0.02 | 0.03 |
Quick Ratio | 0.16 | 0.22 | 0.35 | 0.29 | 0.22 | 0.34 | 0.25 | 0.18 | 0.13 | 0.19 | 1.35 | 4.08 | 7.94 | 24.86 | 2.52 | 4.62 |
Current Ratio | 0.16 | 0.22 | 0.35 | 0.29 | 0.22 | 0.34 | 0.25 | 0.18 | 0.13 | 0.19 | 1.35 | 4.08 | 7.94 | 24.86 | 2.52 | 4.62 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -7.45 | -7.06 | -6.64 | -4.77 | -8.4 | -12.8 | -12.8 | -10.76 | -43.36 | -6K | -3.12K | -2.63K | -1.81K | -12.28K | -2.37K | -1.07K |
Return on Equity | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | 0.03 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -0.19 | -0.21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |